Samuel T Henderson

Summary

Affiliation: University of Colorado
Country: USA

Publications

  1. ncbi Ketone bodies as a therapeutic for Alzheimer's disease
    Samuel T Henderson
    Accera, Inc, Broomfield, Colorado 80021, USA
    Neurotherapeutics 5:470-80. 2008
  2. ncbi High carbohydrate diets and Alzheimer's disease
    Samuel T Henderson
    Accera Inc and Institute for Behavioral Genetics, University of Colorado, 1480 30th Street, Boulder, CO 80303, USA
    Med Hypotheses 62:689-700. 2004
  3. ncbi Effects of beta-hydroxybutyrate on cognition in memory-impaired adults
    Mark A Reger
    Accera, Inc, Aurora, CO 80010, USA
    Neurobiol Aging 25:311-4. 2004

Collaborators

  • S Craft
  • Mark A Reger
  • G S Watson
  • Laura D Baker
  • Darla Chapman
  • Cathy Hale
  • Karen Hyde
  • Brenna Cholerton

Detail Information

Publications3

  1. ncbi Ketone bodies as a therapeutic for Alzheimer's disease
    Samuel T Henderson
    Accera, Inc, Broomfield, Colorado 80021, USA
    Neurotherapeutics 5:470-80. 2008
    ..Research into the therapeutic potential of KB and ketosis represents a promising new area of AD research...
  2. ncbi High carbohydrate diets and Alzheimer's disease
    Samuel T Henderson
    Accera Inc and Institute for Behavioral Genetics, University of Colorado, 1480 30th Street, Boulder, CO 80303, USA
    Med Hypotheses 62:689-700. 2004
    ..Interventions that restore lipid homeostasis may treat the disease, including drugs that increase fatty acid metabolism, EFA repletion therapy, and ketone body treatment...
  3. ncbi Effects of beta-hydroxybutyrate on cognition in memory-impaired adults
    Mark A Reger
    Accera, Inc, Aurora, CO 80010, USA
    Neurobiol Aging 25:311-4. 2004
    ..02). Additional research is warranted to determine the therapeutic benefits of MCTs for patients with AD and how APOE-4 status may mediate beta-OHB efficacy...